Arcadia Biosciences, Inc. (NASDAQ:RKDA) Sees Significant Decrease in Short Interest

Arcadia Biosciences, Inc. (NASDAQ:RKDA) was the recipient of a large decrease in short interest in November. As of November 15th, there was short interest totalling 19,600 shares, a decrease of 21.3% from the October 31st total of 24,900 shares. Based on an average daily volume of 14,400 shares, the short-interest ratio is currently 1.4 days. Approximately 1.4% of the shares of the company are sold short.

Analyst Upgrades and Downgrades

RKDA has been the topic of several analyst reports. StockNews.com assumed coverage on Arcadia Biosciences in a research report on Saturday, November 23rd. They set a “sell” rating on the stock. HC Wainwright reaffirmed a “buy” rating and issued a $6.00 price objective on shares of Arcadia Biosciences in a research note on Wednesday, August 21st.

Arcadia Biosciences Price Performance

Shares of NASDAQ RKDA opened at $2.76 on Friday. The stock has a market cap of $3.75 million, a PE ratio of -0.64 and a beta of 1.27. Arcadia Biosciences has a 1 year low of $1.85 and a 1 year high of $5.34. The firm has a fifty day moving average price of $3.33 and a 200-day moving average price of $3.07.

About Arcadia Biosciences

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.